They include (1) pre-loaded red fluorescent, anti-ROR1 trapping layer (glass fiber), (2) flow layer (wax print chromatography paper), (3) erythrocyte buffy coat sample with quantified cancer cells, and (4) blunt tip syringes for uniform droplet application. This evidence concerns the gene ROR1 and cancer.